Skip to content
  • Sunday, 26 July 2026
  • 1:48 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • TWiV 1290: Clinical Update with Dr. Daniel Griffin Explores Screwworm, Shingles Vaccine’s Anti-Aging Potential, and Critical Public Health Data.
Microbiology & Immunology

TWiV 1290: Clinical Update with Dr. Daniel Griffin Explores Screwworm, Shingles Vaccine’s Anti-Aging Potential, and Critical Public Health Data.

Lina Irawan Apr 23, 2026 0

In a recent episode of "This Week in Virology" (TWiV), Dr. Daniel Griffin provided his weekly clinical update, delving into…

Read More
Microbiology & Immunology

TWiV 1290: Clinical Update with Dr. Daniel Griffin Explores Diverse Medical Topics from Screwworm to Scientific Advocacy

Lina Irawan Apr 2, 2026 0

In a comprehensive clinical update featured on "This Week in Virology" (TWiV) episode 1290, Dr. Daniel Griffin, alongside host Vincent…

Read More
Microbiology & Immunology

TWiV 1290: Clinical Update with Dr. Daniel Griffin Discusses Screwworm, Shingles Vaccine’s Anti-Aging Effects, and Current Public Health Data

Lina Irawan Mar 25, 2026 0

In a recent clinical update featured on "This Week in Virology" (TWiV) episode 1290, Dr. Daniel Griffin provided a comprehensive…

Read More
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful DifferentiationThe Critical Role of Oxygen Levels During Planetary Core Formation in Determining Life’s PotentialCan geoengineering blunt El Niño’s fury?Texas A&M University Researchers Develop Breakthrough Nasal Spray to Reverse Brain Aging and Combat Neurodegenerative Decline
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ